TrialOral oncology2025

Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).

Philipp Schröter et al.PubMed ↗Publisher ↗

No numbers read from the abstract.